Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

Below are the newest and most recently updated Shortage and Discontinuation reports.

Drug pills

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
MIDAZOLAM INJECTION USP PFIZER CANADA ULC Actual shortage 5MG Updated Report 2019-04-26 72818
CANDESARTAN SANIS HEALTH INC Actual shortage 16MG Updated Report 2019-04-26 80863
VOLTAREN OPHTHA NOVARTIS PHARMACEUTICALS CANADA INC Anticipated shortage 0.1% Updated Report 2019-04-26 71606
TOBREX NOVARTIS PHARMACEUTICALS CANADA INC Resolved 3MG Updated Report 2019-04-26 80771
VASERETIC MERCK CANADA INC Resolved 25MG 8MG Updated Report 2019-04-26 79221
TEVA-CARBAMAZEPINE TEVA CANADA LIMITED Actual shortage 200MG Updated Report 2019-04-26 82410
MONTELUKAST SODIUM TABLETS ACCORD HEALTHCARE INC Resolved 10MG Updated Report 2019-04-26 62913
OLMETEC MERCK CANADA INC Resolved 20MG Updated Report 2019-04-26 78421
INNOHEP LEO PHARMA INC Resolved 20000UNIT Updated Report 2019-04-26 79586
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN PHARMACEUTICALS ULC Actual shortage 300MG 200MG Updated Report 2019-04-26 82201

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
GD-QUINAPRIL GENMED A DIVISION OF PFIZER CANADA ULC Discontinued 20MG Updated Report 2019-04-24 62050
VOLTAREN SR NOVARTIS PHARMACEUTICALS CANADA INC To be discontinued 100MG Updated Report 2019-04-23 80298
RANITIDINE SIVEM PHARMACEUTICALS ULC To be discontinued 150MG Updated Report 2019-04-22 76211
ATORVASTATIN-10 SIVEM PHARMACEUTICALS ULC To be discontinued 10MG Updated Report 2019-04-22 70938
ATENOLOL SIVEM PHARMACEUTICALS ULC To be discontinued 50MG Updated Report 2019-04-22 70935
STATEX SYRUP 1MG/ML PALADIN LABS INC To be discontinued 1MG New Report 2019-04-18 81996
STATEX DPS 50MG/ML PALADIN LABS INC Discontinued Updated Report 2019-04-18 81954
RIVA-OLMESARTAN LABORATOIRE RIVA INC Discontinued 20MG Updated Report 2019-04-18 81926
RIVA-OLMESARTAN LABORATOIRE RIVA INC Discontinued 40MG Updated Report 2019-04-18 81929
ULTRAVIST 240 BAYER INC Discontinued 50% New Report 2019-04-17 81959
ATORVASTATIN-20 SIVEM PHARMACEUTICALS ULC To be discontinued 20MG Updated Report 2019-04-15 70941
ATORVASTATIN-80 SIVEM PHARMACEUTICALS ULC To be discontinued 80MG Updated Report 2019-04-15 70947
BROMAZEPAM-6 - TAB 6MG PRO DOC LIMITEE To be discontinued 6MG New Report 2019-04-11 81471
ACT DILTIAZEM CD TEVA CANADA LIMITED Discontinued 180MG New Report 2019-04-11 81418
TEVA-LISINOPRIL (TYPE P) TEVA CANADA LIMITED Discontinued 10MG New Report 2019-04-11 81400
NOVAMOXIN TEVA CANADA LIMITED Discontinued 25MG New Report 2019-04-11 81393
TEVA-LAMOTRIGINE TEVA CANADA LIMITED Discontinued 25MG New Report 2019-04-11 81388
ACT DILTIAZEM CD TEVA CANADA LIMITED Discontinued 120MG New Report 2019-04-11 81381
TEVA-PREDNISONE TEVA CANADA LIMITED Discontinued 5MG New Report 2019-04-11 81376
TEVA-FAMOTIDINE TEVA CANADA LIMITED Discontinued 20MG New Report 2019-04-11 81371